petiq is founded with a love of pets and a desire to improve pet lives with veterinarian recommended pet products, made here in the usa. petiq offers pet prescription medications, over-the-counter flea & tick preventatives, health & wellness supplements, and dog & cat treats - at savings to other brand name alternatives. the company's portfolio of brands includes minties® dental treats, advecta® and petaction® flea and tick preventatives, vetiq® health & wellness, delightibles® cat treats, and betsy farms® dog treats. products are distributed nationally through traditional retail partners. petiq is headquartered in eagle, idaho with manufacturing and distribution facilities in springville, utah; plano, texas; and daytona beach, florida. to learn more, visit petiq.com.
Company profile
Ticker
PETQ
Exchange
Website
CEO
McCord Christensen
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
ECP IV TS Investor Co. • PetIQ Holdings, LLC • PetIQ, LLC • Mark and Chappell Limited • PetIQ MFG, LLC • Community Veterinary Clinics, LLC • Sergeant’s Pet Care Products, LLC • Velcera, LLC ...
PETQ stock data
Latest filings (excl ownership)
10-K
2023 FY
Annual report
29 Feb 24
8-K
PetIQ, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
28 Feb 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
8-K
PetIQ, Inc. Reports Third Quarter 2023 Financial Results
7 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
8-K
PetIQ, Inc. Reports Second Quarter 2023 Financial Results
8 Aug 23
8-K
Departure of Directors or Certain Officers
3 Aug 23
8-K
Departure of Directors or Certain Officers
26 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
22 Jun 23
8-K
Entry into a Material Definitive Agreement
31 May 23
Transcripts
PETQ
Earnings call transcript
2023 Q4
28 Feb 24
PETQ
Earnings call transcript
2023 Q3
7 Nov 23
PETQ
Earnings call transcript
2023 Q2
8 Aug 23
PETQ
Earnings call transcript
2023 Q1
9 May 23
PETQ
Earnings call transcript
2022 Q4
28 Feb 23
PETQ
Earnings call transcript
2022 Q3
10 Nov 22
PETQ
Earnings call transcript
2022 Q2
13 Aug 22
PETQ
Earnings call transcript
2022 Q1
5 May 22
PETQ
Earnings call transcript
2021 Q4
2 Mar 22
PETQ
Earnings call transcript
2021 Q3
4 Nov 21
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 137 |
Opened positions | 17 |
Closed positions | 25 |
Increased positions | 51 |
Reduced positions | 45 |
13F shares | Current |
---|---|
Total value | 370.95 bn |
Total shares | 29.65 mm |
Total puts | 56.50 k |
Total calls | 321.20 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 2.09 mm | $31.71 bn |
Eos Management | 1.97 mm | $29.93 bn |
Ecp Helios Partners Iv | 1.97 mm | $0.00 |
Vanguard | 1.69 mm | $25.66 bn |
Applied Fundamental Research | 1.59 mm | $24.18 bn |
Aristotle Capital Boston | 1.28 mm | $19.47 bn |
Alger Associates | 1.23 mm | $31.83 mm |
Boston Partners | 1.10 mm | $17.05 bn |
Nepsis | 957.33 k | $14.52 bn |
Division of Investment, Department of the Treasury, State of New Jersey | 832.00 k | $35.00 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Mar 24 | Christensen McCord | Class A Common Stock | Payment of exercise | Dispose F | No | No | 16.57 | 2,236 | 37.05 k | 145,675 |
12 Mar 24 | Christensen McCord | Class A Common Stock | Option exercise | Acquire M | No | No | 0 | 5,680 | 0.00 | 147,911 |
12 Mar 24 | Christensen McCord | RSU Class A Common Stock | Option exercise | Dispose M | No | No | 0 | 5,680 | 0.00 | 0 |
12 Mar 24 | Smith Michael A | Class A Common Stock | Payment of exercise | Dispose F | No | No | 16.57 | 714 | 11.83 k | 66,903 |
12 Mar 24 | Smith Michael A | Class A Common Stock | Option exercise | Acquire M | No | No | 0 | 1,581 | 0.00 | 67,617 |
12 Mar 24 | Smith Michael A | RSU Class A Common Stock | Option exercise | Dispose M | No | No | 0 | 1,581 | 0.00 | 0 |
2 Mar 24 | Zvi Glasman | Class A Common Stock | Payment of exercise | Dispose F | No | No | 17.37 | 6,562 | 113.98 k | 24,200 |
2 Mar 24 | Zvi Glasman | Class A Common Stock | Option exercise | Acquire M | No | No | 0 | 12,931 | 0.00 | 30,762 |
2 Mar 24 | Zvi Glasman | RSU Class A Common Stock | Option exercise | Dispose M | No | No | 0 | 12,931 | 0.00 | 38,794 |
2 Mar 24 | Christensen McCord | Class A Common Stock | Payment of exercise | Dispose F | No | No | 17.37 | 18,354 | 318.81 k | 142,231 |
News
Jefferies Maintains Buy on PetIQ, Raises Price Target to $28
19 Mar 24
PETQ Expects Net Sales Of $1.13B-$1.18B For 2024 (Est $1.126B), $290M-$310M For Q1 (Est $306.81M)
28 Feb 24
PetIQ: Q4 Earnings Insights
28 Feb 24
PetIQ Q4 2023 Adj EPS $(0.12) Beats $(0.29) Estimate, Sales $219.93M Beat $189.05M Estimate
28 Feb 24
Earnings Scheduled For February 28, 2024
28 Feb 24